ro-16-0154 and Cerebellar-Ataxia

ro-16-0154 has been researched along with Cerebellar-Ataxia* in 2 studies

Other Studies

2 other study(ies) available for ro-16-0154 and Cerebellar-Ataxia

Article	Year
Experience of (123)I-iomazenil SPECT study for crossed cerebellocerebral diaschisis: report of two cases. Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:9 Topics: Aged; Cerebellar Ataxia; Cerebellar Diseases; Cerebral Angiography; Flumazenil; Headache; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2012
Single-photon emission computed tomography image of benzodiazepine receptors in a patient with Creutzfeldt-Jakob disease. Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:10 A 50-year-old woman presented with progressive visual disturbance, ataxia, and dementia. The cerebral cortex became atrophic, as the disease progressed, and electroencephalography showed periodic synchronous discharges. The patient's prion gene revealed a point mutation (232Met to Arg), and a diagnosis of Creutzfeldt-Jakob disease was made. Iomazenil single-photon emission computed tomography (SPECT) was performed to assess neuronal degeneration. Accumulation of the tracer in the late images was severely decreased diffusely spread throughout the cerebral cortex. Our experience with this case suggests that iomazenil SPECT is useful for detecting neuronal degeneration in Creutzfeldt-Jakob disease. Topics: Brain; Brain Chemistry; Cerebellar Ataxia; Creutzfeldt-Jakob Syndrome; Female; Flumazenil; Humans; Middle Aged; Myoclonus; Nerve Degeneration; Nerve Tissue Proteins; Point Mutation; PrPC Proteins; Receptors, GABA-A; Tomography, Emission-Computed, Single-Photon	1998

Article

Year

Experience of (123)I-iomazenil SPECT study for crossed cerebellocerebral diaschisis: report of two cases.

Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:9

Topics: Aged; Cerebellar Ataxia; Cerebellar Diseases; Cerebral Angiography; Flumazenil; Headache; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2012

Single-photon emission computed tomography image of benzodiazepine receptors in a patient with Creutzfeldt-Jakob disease.

Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:10

A 50-year-old woman presented with progressive visual disturbance, ataxia, and dementia. The cerebral cortex became atrophic, as the disease progressed, and electroencephalography showed periodic synchronous discharges. The patient's prion gene revealed a point mutation (232Met to Arg), and a diagnosis of Creutzfeldt-Jakob disease was made. Iomazenil single-photon emission computed tomography (SPECT) was performed to assess neuronal degeneration. Accumulation of the tracer in the late images was severely decreased diffusely spread throughout the cerebral cortex. Our experience with this case suggests that iomazenil SPECT is useful for detecting neuronal degeneration in Creutzfeldt-Jakob disease.

Topics: Brain; Brain Chemistry; Cerebellar Ataxia; Creutzfeldt-Jakob Syndrome; Female; Flumazenil; Humans; Middle Aged; Myoclonus; Nerve Degeneration; Nerve Tissue Proteins; Point Mutation; PrPC Proteins; Receptors, GABA-A; Tomography, Emission-Computed, Single-Photon

1998